Laborie Medical Technologies Agrees to Acquire Urotronic

Palo Alto – September 6, 2023 – Cooley advised Laborie Medical Technologies, a top diagnostic and therapeutic medical technology company, on patent and licensing matters relating to its definitive agreement to acquire Urotronic. Partner Mika Reiner Mayer led the Cooley team advising Laborie on patent matters, with support from patent agent Lisa Amii, while partner Kate Hillier led the Cooley team advising Laborie on licensing matters.

Under the terms of the agreement, the transaction consists of an upfront cash payment of $255 million, and up to an additional $345 million in potential commercial and reimbursement milestone payments. Because of Laborie’s existing minority investment in Urotronic, the net upfront cash payment will be $232 million, with net potential milestone payments of up to $314 million.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has nearly 1,400 lawyers across 18 offices in the United States, Asia and Europe, and a total workforce of more than 3,000.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.